ストックスクリーナーアプリを入手
2.06
0.00%
0.00
Mural Oncology Plc (MURA) 最新ニュース
Evaluating Mural Oncology plc with trendline analysis2025 Performance Recap & Real-Time Chart Breakout Alerts - Newser
Citadel Group discloses 1.53% stake in Mural Oncology By Investing.com - Investing.com Canada
How to forecast Mural Oncology plc trends using time seriesJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
Can Mural Oncology plc recover in the next quarterJuly 2025 Institutional & Verified Short-Term Plans - Newser
Volume spikes in Mural Oncology plc stock – what they meanEarnings Miss & Verified Trade Idea Suggestions - Newser
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Mural Oncology plc (NASDAQ: MURA) - PR Newswire
Published on: 2025-08-27 15:58:19 - Newser
Using AI based signals to follow Mural Oncology plcWeekly Stock Summary & Proven Capital Preservation Methods - Newser
Published on: 2025-08-27 14:46:00 - Newser
Is Mural Oncology plc meeting your algorithmic filter criteriaTrade Performance Summary & Precise Buy Zone Tips - Newser
Published on: 2025-08-27 13:10:25 - Newser
Mural Oncology plc stock trendline breakdown2025 Trading Volume Trends & Safe Entry Trade Reports - Newser
Form 8.3Mural Oncology plc - Business Wire
Citadel Group discloses 1.53% stake in Mural Oncology - Investing.com
Visual analytics tools that track Mural Oncology plc performanceTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
Citadel Group discloses 2.1% stake in Mural Oncology By Investing.com - Investing.com Canada
Can momentum traders help lift Mural Oncology plcMarket Risk Analysis & Consistent Return Strategy Ideas - Newser
Mural Oncology plc stock momentum explainedJuly 2025 Outlook & Low Risk High Win Rate Picks - Newser
Tick level data insight on Mural Oncology plc volatilityPortfolio Update Report & Long-Term Safe Investment Plans - Newser
Is Mural Oncology plc stock poised for growthWeekly Gains Report & Safe Capital Growth Trade Ideas - Newser
Using flow based indicators on Mural Oncology plc2025 Price Targets & Long-Term Capital Growth Strategies - Newser
Published on: 2025-08-26 10:48:02 - Newser
Citadel Group discloses 1.61% stake in Mural Oncology - Investing.com
Citadel Group discloses 2.1% stake in Mural Oncology - Investing.com
Key metrics from Mural Oncology plc’s quarterly dataWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Aug Wrap: Is Mural Oncology plc showing insider buyingJuly 2025 Drop Watch & Daily Stock Momentum Reports - sundaytimes.kr
Technical Models Detect Momentum Build in Mural Oncology plc - 더경남뉴스
Backtesting results for Mural Oncology plc trading strategiesJuly 2025 Sentiment & Expert Curated Trade Ideas - Newser
What technical models suggest about Mural Oncology plc’s comebackTrade Analysis Summary & Scalable Portfolio Growth Ideas - Newser
Will Mural Oncology plc be affected by tariffsWeekly Investment Report & Stepwise Trade Signal Implementation - theviewers.co.kr
Candlestick signals on Mural Oncology plc stock todayJuly 2025 Closing Moves & Free Safe Entry Trade Signal Reports - Newser
Is Mural Oncology plc exposed to political riskMarket Movers & Low Risk Entry Point Tips - theviewers.co.kr
What moving averages say about Mural Oncology plcWeekly Trade Review & Weekly Top Gainers Trade List - Newser
Citadel Group discloses 2.33% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 2.33% stake in Mural Oncology - Investing.com
Mural Oncology plc Recovery Likely Here’s What Data ShowsJuly 2025 Drop Watch & Expert-Curated Trade Recommendations - 더경남뉴스
Mural Oncology To Be Acquired By XOMA Royalty - MSN
Xoma Acquires Mural Oncology in Latest Deal to Acquire 'Zombie' Biotech - AInvest
Mural Oncology plc Approaches Psychological Resistance LevelQuarterly Profit Summary & High Conviction Investment Ideas - 클래시안
Xoma Royalty Corporation shares fall 1.92% after-hours following Vanguard Group's disclosure of Mural Oncology plc position. - AInvest
Can Mural Oncology plc be the next market leaderJuly 2025 Action & Fast Gain Stock Tips - theviewers.co.kr
Citadel Group discloses 2.81% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.44% stake in Mural Oncology By Investing.com - Investing.com Australia
Mural Oncology accepts XOMA takeover bid - The Pharma Letter
Will Mural Oncology plc Stock Benefit from AI and Green Energy TrendsGlobal Markets & Reliable Intraday Trade Plans - Newser
Mural Oncology to be Acquired by XOMA Royalty for $36.2 Million - AInvest
Mural Oncology to be Acquired by XOMA Royalty for $2.035-$2.24 per Share in Cash Deal - AInvest
Xoma, a drug royalty specialist, buys another ‘zombie’ biotech - BioPharma Dive
MURA’s Unexpected Surge: Analyzing Stock Movement - StocksToTrade
Mural Oncology to be Acquired by XRA 5 - citybiz
XOMA Royalty Corporation entered into a definitive agreement to acquire Mural Oncology plc for $35.3 million. - MarketScreener
Mural Oncology plc enters acquisition agreement with XRA 5 Corp (XOMA Royalty Corporation) - Arthur Cox LLP
After culling 90% of staff, Waltham biotech finds buyer - NBC Boston
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):